Correlation Between Spandana Sphoorty and Beta Drugs

Can any of the company-specific risk be diversified away by investing in both Spandana Sphoorty and Beta Drugs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spandana Sphoorty and Beta Drugs into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Spandana Sphoorty Financial and Beta Drugs, you can compare the effects of market volatilities on Spandana Sphoorty and Beta Drugs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spandana Sphoorty with a short position of Beta Drugs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spandana Sphoorty and Beta Drugs.

Diversification Opportunities for Spandana Sphoorty and Beta Drugs

-0.69

Correlation Coefficient

Spandana Sphoorty  Beta Drugs

Excellent diversification

The 3 months correlation between Spandana and Beta is -0.69. Overlapping area represents the amount of risk that can be diversified away by holding Spandana Sphoorty Financial and Beta Drugs in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Beta Drugs and Spandana Sphoorty is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spandana Sphoorty Financial are associated (or correlated) with Beta Drugs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Beta Drugs has no effect on the direction of Spandana Sphoorty i.e., Spandana Sphoorty and Beta Drugs go up and down completely randomly.

Pair Corralation between Spandana Sphoorty and Beta Drugs

Assuming the 90 days trading horizon Spandana Sphoorty Financial is expected to generate 2.57 times more return on investment than Beta Drugs. However, Spandana Sphoorty is 2.57 times more volatile than Beta Drugs. It trades about 0.15 of its potential returns per unit of risk. Beta Drugs is currently generating about -0.19 per unit of risk. If you would invest  38,475  in Spandana Sphoorty Financial on October 12, 2024 and sell it today you would earn a total of  6,610  from holding Spandana Sphoorty Financial or generate 17.18% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Spandana Sphoorty Financial  vs.  Beta Drugs

Spandana Sphoorty

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Spandana Sphoorty Financial has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Beta Drugs

Risk-Adjusted Performance

6 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Beta Drugs are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Beta Drugs unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Spandana Sphoorty and Beta Drugs

The main advantage of trading using opposite Spandana Sphoorty and Beta Drugs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spandana Sphoorty position performs unexpectedly, Beta Drugs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Beta Drugs will offset losses from the drop in Beta Drugs' long position.

The idea behind Spandana Sphoorty Financial and Beta Drugs pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.